The Board of Directors of Cengild Medical Berhad wishes to announce that the Company intends to seek shareholders' approval at its Sixth Annual General Meeting for the Proposed Renewal of Existing Shareholders' Mandate for Recurrent Related Party Transactions of a Revenue or Trading Nature.

 The Circular to Shareholders, outlining the details of the above proposed renewal, will be issued in due course.

 This announcement is dated 6 October 2026.